Chugai Pharmaceutical (OTCMKTS:CHGCY) Shares Gap Down – Should You Sell?

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY) shares gapped down before the market opened on Wednesday . The stock had previously closed at $26.71, but opened at $25.50. Chugai Pharmaceutical shares last traded at $26.8525, with a volume of 5,682 shares.

Chugai Pharmaceutical Stock Performance

The company has a fifty day simple moving average of $25.34 and a two-hundred day simple moving average of $24.13. The firm has a market capitalization of $87.51 billion, a PE ratio of 33.24 and a beta of 0.63.

Chugai Pharmaceutical (OTCMKTS:CHGCY) last released its quarterly earnings data on Friday, October 24th. The company reported $0.23 earnings per share for the quarter. Chugai Pharmaceutical had a return on equity of 20.63% and a net margin of 32.74%.The firm had revenue of $2.26 billion during the quarter. On average, equities analysts anticipate that Chugai Pharmaceutical Co., Ltd. Unsponsored ADR will post 0.74 earnings per share for the current fiscal year.

About Chugai Pharmaceutical

Chugai Pharmaceutical Co, Ltd. is a Japan-based biopharmaceutical company headquartered in Tokyo that focuses on the discovery, development, manufacture and marketing of prescription medicines. The company develops both biologics and small-molecule therapies, with particular emphasis on oncology and immunology as well as treatments for bone and metabolic disorders. Chugai’s activities span the full drug lifecycle from early research and clinical development through regulatory approval, manufacturing and post-marketing support.

Chugai is known for its research-driven approach and its work on monoclonal antibodies and other biologic therapeutics.